FDA 483 - ACRX Specialty Pharmacy Inc - July 23, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
This FDA Form 483 details observations from an inspection of ACRX Specialty Pharmacy Inc., a producer of sterile and non-sterile drug products, located at 3200 Soaring Gulls Dr Ste 101, Las Vegas, NV 89129-2198. The inspection occurred from July 12, 2021, to July 23, 2021. The report was issued to Eghomware J. Igbinovia, Owner and Pharmacist-in-Charge.
Seven observations were noted: 1. **ISO 5 Aseptic Processing Area Cleanliness:** The ISO 5 classified aseptic processing areas contained difficult-to-clean and visibly dirty equipment/surfaces, which were not cleaned before and after producing Glutathione (BUD MDV) 200 mg/ml Inject Soln, Lot #07122021@8. Specific issues included brownish stains on the HEPA filter cover and frames, a difficult-to-clean gap in a stainless-steel bar pot rack, and unknown stains under light bulbs. 2. **Non-Microbial Contamination:** Dusty, filth-like material was present on a non-sterile hood used for non-sterile and sterile product ingredients. Unknown powders were found on the working surface after cleaning, and unknown stains were on the interior of a hood's front window. Rust-
ID · ae5708e1-f33e-4046-8aca-7c6cd8ae1fcb